Integra Lifesciences Holdings Corp (IART)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$9.26
Buy
$9.82
$-0.04 (-0.42%)
Prices updated at 02 Apr 2026, 21:04 EDT
| Prices minimum 15 mins delay
Prices in USD
Integra Lifesciences Holdings Corp is engaged in development, manufacturing, and marketing of product lines from its technology for applications ranging from burn and deep tissue wounds to repair of dura mater in the brain to repair of nerve and tendon.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Stuart M. Essig, PhD
CEO
Ms. Mojdeh Poul
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
4,427
Head office
1100 Campus Road
Princeton
United States
08540
Key personnel
Owner name | Salary |
|---|---|
Mr. Christian Stanton Schade Independent Director | 0.12m |
Dr. Jeffrey A. Graves Independent Director | 0.05m |
Ms. Barbara B. Hill Presiding Independent Director | 0.05m |
Dr. Keith Bradley,PhD Independent Director | 0.08m |
Mr. Stuart M. Essig, PhD Executive Chairman of the Board | 0.12m |
Mr. Jeffrey A. Mosebrook Senior Vice President, Finance and Principal Accounting Officer | - |
Ms. Mojdeh Poul President, Chief Executive Officer and Director | - |
Ms. Shaundra D. Clay Independent Director | 0.08m |
Ms. Renee Wonlai Lo Independent Director | 0.08m |
Ms. Lea Daniels Knight Executive Vice President and Chief Financial Officer | 0.62m |
Mr. Eric I. Schwartz Executive Vice President, Chief Legal Officer and Secretary | - |
Mr. Robert T. Davis, Jr Executive Vice President and President, Tissue Technologies | 0.54m |
Mr. Michael McBreen Executive Vice President and President, Codman Specialty Surgical | 0.64m |
Mr. Harvinder Singh Executive Vice President and President, International | 0.51m |
Ms. Chantal Veillon-Berteloot Executive Vice President and Chief Human Resources Officer | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| BlackRock Inc | 10,229,183 |
| Rubric Capital Management LP | 7,753,934 |
| BlackRock Fund Advisors | 7,312,373 |
| Fuller & Thaler Asset Management Inc | 7,272,720 |
| Vanguard Group Inc | 7,210,624 |
Director dealings
Date | Action |
|---|---|
| 05 Nov 2025 | - |
| 12 Oct 2025 | - |
| 12 Oct 2025 | - |
| 12 Oct 2025 | - |
| 01 Sep 2025 | - |
| 01 Sep 2025 | - |
| 14 Aug 2025 | - |
| 14 Aug 2025 | - |
| 03 Jul 2025 | - |
| 03 Jul 2025 | - |
| 01 Jul 2025 | - |
| 09 May 2025 | - |
| 09 May 2025 | - |
| 09 May 2025 | - |
| 09 May 2025 | - |
| 09 May 2025 | - |
| 09 May 2025 | - |
| 09 May 2025 | - |
| 09 May 2025 | - |
| 09 May 2025 | - |
Please note that past performance is not a reliable indicator of future returns.
